Search Results for: Recent Advancements in Drug Delivery
Articles
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing: Anticipating the Needs of the Future May 5, 2015
Contributor Cindy H. Dubin speaks with several companies in the prefilled syringe and parenteral manufacturing market that are offering a range of services and systems that cater to today’s issues as well as anticipating the needs of the future.
Combination Product Technology to Reach $31 Billion; Sector Attracting Massive Developmental Companies March 10, 2015
BCC Research reveals in its new report on drug-device combination products, developments in cell-based therapeutics, progenitor cell exploitation, growth factor...SPECIAL FEATURE - Bioavailability & Solubility: A Demand for Enhanced Technologies & Materials is Spurring Innovation March 3, 2015
Contributor Cindy H. Dubin spoke with several contract research/manufacturing organizations on how they are successfully overcoming solubility/bioavailability challenges, such as matching APIs to formulations and choosing the best excipients.
Credence MedSystems' Innovative Companion Safety Syringe System Earns Multiple Industry Awards March 2, 2015
Credence MedSystems’ Innovative Companion Safety Syringe System Earns Multiple Industry Awards Credence MedSystems, Inc. recently announced the Credence Companion Safety...CSL Behring Signs Strategic Agreement With Enable Injections October 31, 2014
CSL Behring LLC recently announced its affiliate company, CSL Behring AG, of Bern, Switzerland, and Enable Injections, LLC, of Franklin,...INJECTABLE MICROEMULSIONS - Prolonged-Release Injectable Microemulsions: Opportunities for Pain Treatment June 4, 2014
Rajesh Dubey, PhD, and Luigi G. Martini, FRPharmS, MBA, indicate available technologies do not support development of certain formulations to treat pain; however, microemulsions with their unique features, can provide a viable alternative to develop such formulations.
EXECUTIVE INTERVIEW - Array BioPharma: Steadily Moving to Late-Stage Development, Preparing for Commercialization March 31, 2014
Executive Summary: Ron Squarer, Chief Executive Officer of Array BioPharma, talks about the company’s pipeline and evolution into a fully integrated, commercial-stage biopharmaceutical company.
The Three Big Predictions for the Global Healthcare Market December 11, 2013
Frost & Sullivan recently released its three big predictions for the global healthcare market. Based on a 2013 Search for...BIOAVAILABILITY ENHANCEMENT - Navigating a Broad Spectrum of Solubilization Technologies: Part II of III October 15, 2013
Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc., continues his multiple-part series discussing today’s most challenging issues in solubility.
Catalent Announces Expansion to Improve Bioavailability September 30, 2013
Catalent Pharma Solutions recently announced several advancements and expansion of its OptiMelt Hot Melt Extrusion (HME) capabilities in Somerset, NJ....Tapemark Wins Innovation Award July 8, 2013
Tapemark recently announced that its Snapplicator packaging won the 2013 World of Wipes (WOW) Innovation Award from INDA, Association of...MARKET BRIEF - Controlled Release Technologies: Advancing Toward Targeting Therapeutics June 10, 2013
Frost & Sullivan Analyst Cecilia Van Cauwenberghe, MS, reviews a few recent innovative approaches to controlled release technologies with a focus on some of the therapeutic areas most relevant to the current pharmaceuticals market.
FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
SPECIAL FEATURE - Analytical Instrumentation Gets Faster, Smaller, and Easier to Use March 12, 2013
Contributor Cindy H. Dubin learns that one doesn’t have to be a rocket scientist to use analytical instrumentation. Three leading players in the market showcase their products, all aimed at making analysis easier and faster.
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...Novozymes Biopharma Announces Agreement With EpiVax February 11, 2013
Novozymes Biopharma recently announced a collaborative research agreement with Rhode Island-based biotech company, EpiVax, Inc. to help further the...5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...Caisson Biotech Enters Potential $100 Million Agreement May 6, 2012
Caisson Biotech, L.L.C. recently announced it has entered into a development and license agreement with Novo Nordisk A/S. The agreement...2/1/2011 January 30, 2011
Ligand Pharmaceuticals Forms Drug Development Alliance With Chiva PharmaceuticalsLigand Pharmaceuticals, Inc. recently announced it has entered into a strategic relationship...
